Clinical Trial Update: IMC-A12 in Treating Patients With Advanced Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of IMC-A12 (cixutumumab) in adults with hepatocellular carcinoma has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• IMC-A12 (cixutumumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-12-03